## Abstract ## BACKGROUND. The primary treatments for clinically localized prostate cancer confer equivalent cancer control for most patients but disparate side effects. In the current study, the authors sought to compare healthβrelated quality of life (HRQOL) outcomes after the most commonly used
The preservation of potency after external beam irradiation for prostate cancer
β Scribed by Franklin L. Banker
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 260 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: We review the recent changes in the radiotherapeutic management of clinically localized prostate cancer, including the implementation of three-dimensional (3-d) conformal radiation therapy (3dcrt), biochemical disease-free survival (bned control) using conventional and 3dcrt techniqu
From 1973 to 1979, 163 patients with biopsy proven adenocarcinoma of the prostate were treated with a curative intent utilizing megavoltage external beam irradiation at Rush-Presbyterian-St. Luke's Medical Center or Lutheran General Hospital. The acturial survival at 5 years for the whole group is 7
Background. This paper presents the results of external beam treatment of prostate cancer. Long term results are represented by the US. national averages from the Patterns of Care study. The modern innovations of threedimensional-assisted conformal treatment are also shown to demonstrate the technol